Sonic Healthcare Stock Forecast for 2023 - 2025 - 2030
Updated on 04/27/2024
Sonic Healthcare Stock Forecast and Price Target
The average price target for Sonic Healthcare's stock set by recognized analysts recently is $31.00, which would result in a potential upside of approximately 17.69% if it reached this mark. The estimation is based on a high estimate of $34.94 and a low estimate of $25.95. If you are interested in SHL stock, it is important to also consider its competitors.
17.69% Upside
Sonic Healthcare Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Sonic Healthcare's Price has seen a drop from $23.13 to $0.00 – a 100.00% decrease. In the next year, analysts believe that Fair Value will reach $29.07 – an increase of 100.00%. For the next nine years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PFE Stock Forecast | Pfizer | Outperform |
2
|
$25.40 | Buy/Sell | $32.87 | 20.08% |
| BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$44.85 | Buy/Sell | $58.15 | 21.52% |
| IQV Stock Forecast | IQVIA Holdings | Outperform |
15
|
$234.88 | Buy/Sell | $267.27 | 17.08% |
| IDXX Stock Forecast | IDEXX Laboratories | Outperform |
14
|
$499.30 | Buy/Sell | $583.92 | 20.17% |
| ICLR Stock Forecast | ICON Public | Buy |
16
|
$308.31 | Buy/Sell | $306.07 | 16.77% |
Sonic Healthcare Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Sonic Healthcare's Revenue has grown, rising from $6.83B to $8.17B – a growth of 19.57%. In the next year, analysts believe that Revenue will reach $8.75B – an increase of 7.11%. For the next seven years, the forecast is for Revenue to grow by 47.16%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| LH Stock Forecast | Laboratory Corp of America Hol... | Outperform |
11
|
$198.40 | Buy/Sell | $241.28 | 21.47% |
| SGSN Stock Forecast | SGS | Hold |
18
|
CHF83.14 | Buy/Sell | CHF86.34 | 8.25% |
| DGX Stock Forecast | Quest Diagnostics | Outperform |
10
|
$134.26 | Buy/Sell | $141.17 | 8.00% |
.jpg)
Sonic Healthcare Dividend per Share Forecast for 2023 - 2025 - 2030
Sonic Healthcare's Dividend per Share has grown In the last three years, rising from $0.85 to $1.04 – a growth of 22.35%. In the next year, analysts believe that Dividend per Share will reach $1.06 – an increase of 1.92%. For the next seven years, experts predict that Sonic Healthcare's Dividend per Share will grow at a rate of 70.19%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BVI Stock Forecast | Bureau Veritas | Outperform |
18
|
27.68€ | Buy/Sell | 26.96€ | 11.99% |
| ERF Stock Forecast | Eurofins Scientific | Hold |
18
|
56.64€ | Buy/Sell | 0.00€ | 4.17% |
| CRL Stock Forecast | Charles River Laboratories Int... | Outperform |
16
|
$229.03 | Buy/Sell | $229.97 | 20.84% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| EXAS Stock Forecast | Exact Sciences | Buy |
8
|
$58.85 | Buy/Sell | $90.32 | 50.57% |
| NTRA Stock Forecast | Natera | Outperform |
7
|
$91.66 | Buy/Sell | $74.41 | 12.37% |
| ITRK Stock Forecast | Intertek Group | Outperform |
18
|
£49.48 | Buy/Sell | £44.87 | 6.71% |
Sonic Healthcare EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Sonic Healthcare's EBITDA has grown by 22.49%, rising from $1.05B to $1.28B. For the next year, analysts predict that EBITDA will reach $1.76B – an increase of 37.50%. Over the next seven years, experts believe that Sonic Healthcare's EBITDA will grow at a rate of 91.08%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| RHC Stock Forecast | Ramsay Health Care | Hold |
18
|
$51.46 | Buy/Sell | $56.32 | 8.84% |
| SYNH Stock Forecast | Syneos Health | - |
16
|
$42.98 | Buy/Sell | $43.00 | -100.00% |
| GH Stock Forecast | Guardant Health | Buy |
6
|
$17.35 | Buy/Sell | $43.00 | 153.60% |
Sonic Healthcare EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Sonic Healthcare's EBIT has grown, moving from $814.05M to $1.02B – an increase of 25.19%. In the next year, analysts predict that EBIT will jump to $1.03B – up 1.24% from the current level. Looking ahead to eight years, experts forecast that EBIT will grow by 65.06%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MCOV B Stock Forecast | Medicover AB (publ) | Outperform |
16
|
kr161.00 | Buy/Sell | kr18.54 | -89.55% |
| NEO Stock Forecast | NeoGenomics | Outperform |
8
|
$14.14 | Buy/Sell | $20.09 | 41.44% |
| EVT Stock Forecast | Evotec | Outperform |
14
|
9.24€ | Buy/Sell | 37.33€ | 175.97% |
Sonic Healthcare EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Sonic Healthcare's EPS has seen a drop from $1.13 to $0.00 – a 100.00% decrease. In the next year, analysts believe that EPS will reach $1.42 – an increase of 100.00%. For the next nine years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MYGN Stock Forecast | Myriad Genetics | Hold |
6
|
$18.18 | Buy/Sell | $22.08 | 37.51% |
| APPS Stock Forecast | Applus Services | Outperform |
15
|
12.74€ | Buy/Sell | 10.92€ | -10.13% |
| VCYT Stock Forecast | Veracyte | Outperform |
11
|
$19.31 | Buy/Sell | $32.17 | 68.31% |
.jpg)